Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Michael E. Thase, MD: Editor’s Letter
Michael E. Thase, MD: Editor’s Letter
$
0.00
Michael E. Thase, MD: Editor's Letter quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 40 No. 3 Articles
Tags:
editors-letter
,
invited-commentary
,
michael-e-thase
,
negative-and-failed-clinical-trial-reports
Description
Description
Michael E. Thase, MD
EDITOR’S LETTER
T
WO
N
EW
S
ECTIONS
O
FFER
F
URTHER
C
HECKS AND
B
ALANCES
: N
EGATIVE AND
F
AILED
C
LINICAL
T
RIAL
R
EPORTS AND
I
NVITED
C
OMMENTARY
Michael E. Thase, MD
Share On Facebook
Tweet This Product
Pin This Product
Email This Product
Related products
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 36 Supplement No. 3 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
$
30.00
Add to cart
Details
Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
Michael E. Thase, MD: Editor’s Letter
$0.00
Description
Michael E. Thase, MD
EDITOR’S LETTER
TWO NEW SECTIONS OFFER FURTHER CHECKS AND BALANCES: NEGATIVE AND FAILED CLINICAL TRIAL REPORTS AND INVITED COMMENTARY
Michael E. Thase, MD
Related products
A Model to Explain the Therapeutic Effects of Serotonin Reuptake Inhibitors: The Role of 5-HT2 Receptors
Psychopharmacology Bulletin VOL 36 Supplement No. 3 – Full Issue Stacked PDF
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
Duloxetine for the Treatment of Major Depressive Disorder